TC-99M-HM-PAO BRAIN SPECT IN SUBARACHNOID HEMORRHAGE

被引:1
|
作者
MAINI, CL
CASTELLANO, G
BENECH, F
PODIO, V
CORNAGLIA, G
FONTANELLA, M
机构
[1] Chair of Nuclear Medicine, University of Ancona
[2] Chair of Nuclear Medicine, University of Torino
[3] Institute of Neurosurgery, University of Torino
关键词
D O I
10.1097/00006231-199007000-00005
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Cerebral blood flow (CBF) in subarachnoid haemorrhage (SAH) has been extensively studied using xenon-133. CBF can be imaged by SPECT using HM-PAO: this technique is much easier to perform, but true quantitative data are not available and different diagnostic criteria have to be used. This study investigates the role of HM-PAO SPECT in SAH. Twenty-six HM-PAO SPECT studies were recorded on 24 patients. Fifteen patients were in Hunter and Hess clinical grades I and II and nine were in clinical grades III, IV and V. HM-PAO SPECT showed derangements of brain perfusion in 16 patients. Focal hypoperfusion was observed in 15 patients and focal hyperperfusion in one patient. One patient studied twice had a diffuse hypoperfusion in the first study and focal hypoperfusion in the second. HM-PAO SPECT was more sensitive than transmission computed tomography (CT) in detecting ischaemic complications in the first week (p = 0.064) and in the first two weeks (p = 0.016) after SAH. HM-PAO SPECT also showed altered tissue perfusion in four patients in which not only CT, but also angiography and transcranial Doppler flowmetry were normal. The results obtained lead to the following conclusions: (1) CBF derangements are observed in a high percentage of SAH patients; this percentage is higher among patients with more severe disease (p = 0.048) with focal hypoperfusion being the most common finding; (2) HM-PAO SPECT is more sensitive than CT in evaluating ischaemic complications (p = 0.016) and it can show ischaemia even if no complicating factor, as evaluated by usual neuroradiological procedures, is present; (3) HM-PAO results are associated with the prognosis of the patient (p = 0.155). © 1990 Chapman and Hall Ltd.
引用
收藏
页码:491 / 502
页数:12
相关论文
共 50 条
  • [1] SPECT MEASUREMENTS WITH TC-99M-HM-PAO IN FOCAL EPILEPSY
    RYDING, E
    ROSEN, I
    ELMQVIST, D
    INGVAR, DH
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1988, 8 (06): : S95 - S100
  • [2] METHODOLOGY OF TC-99M-HM-PAO PLATELETS LABELING
    DEMONCEAU, C
    ZIEGELS, P
    RIGO, P
    BRASSEUR, M
    STEGGEN, M
    BALDELLI, L
    BEGUIN, Y
    FILLET, C
    DAVID, JL
    LECLERCQ, R
    DEPRESSEUX, JC
    BOURGEOIS, P
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1988, 14 (5-6): : 301 - 301
  • [3] METHODOLOGY FOR TC-99M-HM-PAO PLATELETS LABELING
    DEMONCEAU, G
    ZIEGELS, P
    RIGO, P
    BRASSEUR, M
    STEGEN, M
    BEGUIN, Y
    FILLET, G
    DAVID, JL
    LECLERCQ, R
    DEPRESSEUX, JC
    BOURGEOIS, P
    JOURNAL OF NUCLEAR MEDICINE, 1988, 29 (07) : 1327 - 1327
  • [4] INITIAL EXPERIENCE WITH TC-99M-HM-PAO IN THE STUDY OF BRAIN-TUMORS
    BABICH, JW
    KEELING, F
    FLOWER, MA
    REPETTO, L
    WHITTON, A
    FIELDING, S
    FULLBROOK, A
    OTT, RJ
    MCCREADY, VR
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1988, 14 (01): : 39 - 44
  • [5] CEREBRAL UPTAKE AND RETENTION OF TC-99M-HEXAMETHYLPROPYLENEAMINE OXIME (TC-99M-HM-PAO)
    HOLMES, RA
    CHAPLIN, SB
    ROYSTON, KG
    HOFFMAN, TJ
    VOLKERT, WA
    NOWOTNIK, DP
    CANNING, LR
    CUMMING, SA
    HARRISON, RC
    HIGLEY, B
    NECHVATAL, G
    PICKETT, RD
    PIPER, IM
    NEIRINCKX, RD
    NUCLEAR MEDICINE COMMUNICATIONS, 1985, 6 (08) : 443 - 447
  • [6] SPECT IMAGING OF MOYAMOYA DISEASE USING TC-99M-HM-PAO - COMPARISON WITH COMPUTED-TOMOGRAPHY FINDINGS
    MOUNTZ, JM
    FOSTER, NL
    ACKERMANN, RJ
    BLUEMLEIN, L
    PETRY, NA
    KUHL, DE
    CT-JOURNAL OF COMPUTED TOMOGRAPHY, 1988, 12 (04): : 247 - 250
  • [7] VALIDITY OF TC-99M-HM-PAO AS A CEREBRAL BLOOD-FLOW TRACER
    INUGAMI, A
    KANNO, I
    UEMURA, K
    SHISHIDO, F
    TOMURA, N
    HIGANO, S
    FUJITA, H
    MURAKAMI, M
    AIZAWA, Y
    NEURORADIOLOGY, 1988, 30 (05) : 460 - 460
  • [8] BRAIN PERFUSION WITH INTRACAROTID INJECTION OF TC-99M-HM-PAO IN PARTIAL EPILEPSY DURING AMOBARBITAL TESTING
    HIETALA, SO
    SILFVENIUS, H
    AASLY, J
    OLIVECRONA, M
    JONSSON, L
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1990, 16 (8-10): : 683 - 687
  • [9] TC-99M HEXAMETHYL-PROPYLENEAMINEOXIME (TC-99M-HM-PAO) - A NEW RADIOPHARMACEUTICAL FOR RCBF IMAGING
    CANNING, LR
    NECHVATAL, G
    CUMMING, SA
    NOWOTNIK, DP
    PICKETT, RD
    NEIRINCKX, RD
    VOLKERT, WA
    TROUTNER, DE
    HOLMES, RA
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1985, 11 (2-3): : A5 - A5
  • [10] COMPARISON OF TC-99M-ECD AND TC-99M-HM-PAO - 1ST HUMAN RESULTS
    DEMONCEAU, G
    LEVEILLE, J
    DEROO, M
    WALOVITCH, R
    WILLIAMS, S
    TAILLEFER, A
    DOUESNARD, JM
    CANTINEAU, R
    RIGO, P
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1988, 14 (5-6): : 227 - 227